XML 15 R4.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
shares in Thousands, $ in Thousands
 3 Months Ended 9 Months Ended
Dec. 31, 2019
Dec. 31, 2018
Dec. 31, 2019
Dec. 31, 2018
Revenues [1] $ 31,655 $ 26,682 $ 83,479 $ 76,689
Cost of revenues 16,978 11,048 37,187 31,387
Gross profit 14,677 15,634 46,292 45,302
Operating expenses:        
Selling 4,067 2,054 8,549 5,748
General and administrative 11,605 7,731 26,806 22,824
Research and development 2,110 860 4,044 2,539
Impairment loss on goodwill and long-lived assets 276 3,669 298 3,669
Legal settlement 3,300
Total operating expenses 18,058 14,314 39,697 38,080
Operating (loss) income (3,381) 1,320 6,595 7,222
Nonoperating expense (income):        
Interest expense and amortization of debt discount 1,929 395 3,522 1,359
Other (income), net (107) (23) (748) (791)
(Loss) earnings before income taxes (5,203) 948 3,821 6,654
Income tax (benefit) expense (573) 90 792 572
Net (loss) income $ (4,630) $ 858 $ 3,029 $ 6,082
Earnings (loss) per share:        
Basic (in dollars per share) $ (1.06) $ 0.22 $ 0.73 $ 1.58
Diluted (in dollars per share) $ (1.06) $ 0.21 $ 0.69 $ 1.51
Weighted-average common shares outstanding:        
Basic (in shares) 4,367 3,855 4,142 3,840
Diluted (in shares) 4,367 4,045 4,418 4,037
[1] Intersegment revenues are not significant and are eliminated to arrive at consolidated totals.